Expressive writing to combat distress associated with the COVID-19 pandemic in people with inflammatory bowel disease (WriteForIBD): A trial protocol

OBJECTIVE: A large proportion of patients with inflammatory bowel disease (IBD) receive immunosuppressive medication, may be at higher risk of complications if they contract SARS-CoV-2 virus, and therefore report high levels of COVID-19-related distress. This trial will evaluate a brief, evidence-ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikocka-Walus, Antonina, Olive, Lisa, Skvarc, David, Beswick, Lauren, Massuger, Wayne, Raven, Leanne, Emerson, Catherine, Evans, Subhadra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609228/
https://www.ncbi.nlm.nih.gov/pubmed/33171431
http://dx.doi.org/10.1016/j.jpsychores.2020.110286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609228/
https://www.ncbi.nlm.nih.gov/pubmed/33171431
http://dx.doi.org/10.1016/j.jpsychores.2020.110286

Ejemplares similares